Directory / Vertical Agents
Delineate
Agents for Accelerated Clinical Trial Design
Headcount
32
▼ -6.1%▲ 10.7%3m · 6m
src: Clay (LinkedIn headcount)
X followers
—
——7d · 30d
Traffic / month
114K
src: Semrush
Latest round
—
SeedJan 19, 2025
// profile
Product
- Agent type
- Research intelligence / retrieval-augmented AI service for extracting and structuring data from scientific literature and patents
- Primary buyer
- Biopharma research, competitive-intelligence, and data-analysis teams
- Integrations
- —
- Pricing
- —
- HQ
- Cambridge, MA, United States
- Founded
- —
- Profile ↗
// capital
Funding
- Round
- Seed
- Amount
- —
- Date
- Jan 19, 2025
- Leads
- Cannage Capital
- Source
- Announcement ↗
- Investors
- Unpopular Ventures, Y Combinator
// team
Hiring
- Employees
- 32
- Growth 3m / 6m
- -6.1% / +10.7%
- Open roles (sample)
- —
- X mentions this week
- —
- X handle
- —
src: Clay (LinkedIn headcount)
src: Clay (LinkedIn headcount)
// x.com
Top launch posts
// awaiting data
No posts tracked yet
This view fills in automatically once the weekly dataset is loaded.
// press
Recent news
// awaiting data
No news tracked yet
This view fills in automatically once the weekly dataset is loaded.
// provenance
Sources
- Headcount
- Clay (LinkedIn headcount)
- Open jobs
- —
- Traffic
- Semrush
- Pricing
- —
- X metrics
- X API public metrics 2026-11-04
- X handle (homepage-verified)
- —
// faq
About Delineate
What does Delineate do?+
Agents for Accelerated Clinical Trial Design
How much has Delineate raised most recently?+
Seed on Jan 19, 2025, led by Cannage Capital.
How many employees does Delineate have?+
About 32 (3-month growth -6.1%).